New tests recommended by the WHO can address TB cases with no or few symptoms more quickly and improve access to life-saving treatment.

For decades, patients being treated for drug-resistant tuberculosis have had to endure a gruelling regimen of daily injections and a cocktail of drugs with severe side effects.

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...

On World TB Day, the World Health Organization (WHO) is urging countries to accelerate action to end tuberculosis (TB) and ...

In the vaccine space, the Gates Medical Research Institute (Gates MRI) is running a Phase III trial of the M72/AS01E vaccine ...

This World Tuberculosis (TB) Day, Médecins Sans Frontières (MSF) urges governments and international donors to bring children to the heart of the global TB response, and commit to investing in the ...

India Launches World's 1St Clinical Trial To Test Ayurveda With TB Treatment. New Delhi, March 24 (IANS) On the occasion of ...

In 2022, World Health Organization (WHO) recommended a shorter six-month, all-oral regimen known as BPaL (M), making ...

India has launched the world’s first clinical trial to study Ayurveda alongside standard TB treatment. The trial will assess ...

A recently released prospective analysis of the first eight years of the Johns Hopkins Medicine-led Zero TB in Kids program ...